Investors Say Shire Tried To Spin Free Of $45M Merger Tab

Law360 (March 2, 2020, 10:47 PM EST) -- Former shareholders of a Shire PLC merger partner told a Delaware vice chancellor Monday the company tried to put its own spin on contract terms in a $325 million merger agreement in an effort to avoid a $45 million post-merger "milestone" payment for an acquired drug prospect.

Laurie Carr Mims of Keker Van Nest & Peters LLP, counsel to Shareholder Representative Services LLC — representing past FerroKin BioSciences Inc. shareholders — told Vice Chancellor Kathaleen S. McCormick during post-trial arguments that Shire breached its contract when it missed a Dec. 31, 2015, deadline to begin a new drug trial phase for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!